Drug shortage
Extended Release · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · To Be Discontinued · updated Aug 31, 2026
Key facts
| Generic name | Extended Release, Metoprolol Succinate Tablet |
|---|---|
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-96) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Cardiovascular |
| Package NDCs | 45963-677-96 |
| First posted | Aug 31, 2026 |
| Last updated | Aug 31, 2026 |
| Discontinued | Aug 31, 2026 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: